Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre-Reference-Cited by-同舟云学术

Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre

Published:2022-04-05 Issue:5 Volume:37 Page:938-946
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Shukla Aakriti Garg^ORCID,Vaidya Sarangdev,Yaghy Antonio,Di Nicola Maura,Kaliki Swathi^ORCID,Fulco Enzo,Myers Jonathan S.,Shields Jerry A.,Shields Carol L.

Funder

American Glaucoma Society

Eye Tumor Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-022-02051-0.pdf

Reference20 articles.

1. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011;118:1881–5. https://doi.org/10.1016/j.ophtha.2011.01.040.

2. Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989–98. https://doi.org/10.1001/archophthalmol.2009.208.

3. Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina 2012;32:1363–72. https://doi.org/10.1097/IAE.0b013e31824d09a8.

4. Shields CL, Shields JA, De Potter P, Singh AD, Hernandez C, Brady LW. Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy. Br J Ophthalmol. 1995;79:306–12. https://doi.org/10.1136/bjo.79.4.306.

5. Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA. Iris melanoma: features and prognosis in 317 children and adults. J AAPOS. 2012;16:10–6. https://doi.org/10.1016/j.jaapos.2011.10.012.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant iridocycline melanoma found in a patient with aplastic anaemia;2023-12-04